Drug targets a biomolecule that can directly bind to drugs and then react. Generally, the target refers to a protein related to the cause of disease. The focus of the target began with focusing on tumors and then began to spread to various fields. Introduction to  ITGA4/ITGB7 is a common target in medicine.

ITGA 4, the integrin subunit alpha 4, is a protein molecule that plays an important role within living organisms. The ITGA 4 gene is a member of the integrin α -chain protein family. Integrins are heterodimeric integral membrane proteins composed of α and β chains that play a key role in cell surface adhesion and signaling. The proproprotein encoded by ITGA 4 was proteolytic processed to generate light and heavy chains containing the alpha 4 subunits. These subunits further bind to the β 1 or β 7 subunits to form integrins with specific functions. The ITGA 4 gene has multiple transcript variants, resulting from alternative splicing. Different transcript variants may be expressed in different tissues or developmental stages and may have different functions.

ITGA 4 plays an important role in cell motility and migration. It participates in the interactions of cells with the extracellular matrix by combining with the β 1 or β 7 subunit and regulates the processes of cell adhesion, migration, and proliferation. In autoimmune diseases such as multiple sclerosis (MS), ITGA 4 assists the migration of leukocytes across the blood-brain barrier, which is one of the important factors in the occurrence and development of diseases. Besides its applications in autoimmune diseases, ITGA 4 may have potential applications in other fields. For example, in tumor studies, ITGA 4 expression is associated with the invasion and metastatic capacity of certain tumors, and may therefore be one of the targets for tumor therapy.

Currently, various immune drugs targeting ITGA4/ITGB7 targets are in the updating iteration, and taking the disease alone or in combination with other products has become a new approach with remarkable achievements. The ITGA4/ITGB7 targets have shown important research value and application prospects in both biology and drug research and development. With further research and detection technology advances, ITGA4/ITGB7 target products are also essential in medical research. Alpha Lifetech can provide  ITGA4/ITGB7 corresponding products and help each customer's research and development. Alpha Lifetech provides end-to-end biotechnology development solutions, from upstream cell culture optimization to downstream purification scale. Our process is validated through analytical techniques such as HPLC, SDS-PAGE, and mass spectrometry to ensure product consistency and regulatory compliance. By combining cutting-edge biotechnology expertise with flexible service models, we help clients accelerate project research progress and ensure smooth experimentation.